T-lymphoblastic lymphoma
MONDO:0044917The most frequent type of lymphoblastic lymphoma. It comprises approximately 85-90% of cases. It is more frequently seen in adolescent males. It frequently presents with a mass lesion in the mediastinum. Pleural effusions are common. (WHO, 2001)
Also known as: Precur. T-lymphoblastic lymphoma, T Lymphoblastic lymphoma, T-Lymphoblastic lymphoma, T-lymphoblastic lymphoma, precursor T Lymphoblastic lymphoma, precursor T-Lymphoblastic lymphoma, precursor T-cell Lymphoblastic lymphoma, precursor T-lymphoblastic lymphoma
1952 clinical trials for this condition and its sub-types, 32 tagged with T-lymphoblastic lymphoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Promising combo for tough leukemia stalls: trial ends early
Disease control Stopped earlyThis phase 2 trial tested two drugs, CB-103 and venetoclax, in adolescents and young adults with T-cell acute lymphoblastic leukemia (T-ALL) that had come back or not responded to treatment. The goal was to see if the combination could control the disease. However, the study was …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug combo for kids with tough leukemia shows promise but trial halted early
Disease control Stopped earlyThis trial tested the drug isatuximab, a targeted antibody, combined with standard chemotherapy in children aged 28 days to under 18 years whose acute leukemia had returned or stopped responding to treatment. The study aimed to see if the combination could help more children achi…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 15:09 UTC